Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129766
Status:
COMPLETED
Last Update Posted:
2013-08-28
First Post:
2005-08-10
Brief Title:
Study of MEDI-524 Motavizumab for the Prophylaxis of Serious Respiratory Syncytial Virus RSV Disease in High-Risk Children
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC